The pill of recovery; Molnupiravir for treatment of COVID-19 patients; a systematic review

BACKGROUND: Throughout the time of the global pandemic of SARS-CoV-2 virus, there has been a compelling necessity for the development of effective antiviral agents and prophylactic vaccines to limit the virus spread, disease burden, hospitalization, and mortality. Until mid of 2021, the NIH treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamal, Lina, Ramadan, Ahmed, Farraj, Suha, Bahig, Lydia, Ezzat, Sameera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906919/
https://www.ncbi.nlm.nih.gov/pubmed/35287313
http://dx.doi.org/10.1016/j.jsps.2022.03.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906919/
https://www.ncbi.nlm.nih.gov/pubmed/35287313
http://dx.doi.org/10.1016/j.jsps.2022.03.002

Ejemplares similares